The use of technetium-99m hexamethylpropylene amine oxime lung scintigraphy in the detection of subclinical lung injury in patients with noninsulin-dependent diabetes mellitus

Nuclear Medicine Communications

Volumn 32, Issue 12, 2011, Pages 1179-1184

  Akkas, Burcu Esen ^a   Gokcora, Nahide ^b   Atasever, Tamer ^b   Yetkin, Ilhan ^c  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Departments of Nuclear Medicine   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

diabetes mellitus; lung injury; Tc 99m HMPAO

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG UPTAKE; FEMALE; GLYCEMIC CONTROL; HUMAN; LUNG INJURY; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIVER; LUNG INJURY; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 80455173821     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834be2af     Document Type: Article

References (33)

1. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 1976; 113:37-41.
2. Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987; 135:223-229.
3. Asanuma Y, Fujiya S, Ide H, Agishi Y. Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1985; 1:95-101.
4. Klein BE, Moss SE, Klein R, Cruickshanks KJ. Peak expiratory flow rate: relationship to risk variables and mortality: the Wisconsin Epidemiologic Study of diabetic retinopathy. Diabetes Care 2001; 24:1967-1971.
5. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004; 27:752-757.
6. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999; 66:14-19.
7. Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa G, et al. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med 1992; 31:189-193.
8. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the US. Diabetes Care 2001; 24:1044-1049.
9. Chang CT, Liu FY, Lin CC, Wang TY, Lee CC, Kao A. Usefulness of techntium-99m hexamethylpropylene amine oxime lung scan to detect subclinical lung injury in patients with noninsulin-dependent diabetes mellitus. J Diabetes Complications 2004; 18:229-232.
10. Hang LW, Shiau YC, Hsu WH, Tsai JJ, Yeh JJ, Kao A. Increased lung uptake of technetium-99m hexamethylpropylene amine oxime in diffuse infiltrative lung disease. Respiration 2003; 70:479-483.
11. Shih CC, Shiau YC, Wang JJ, Ho ST, Kao A. Increased lung uptake of technetium-99m hexamethylpropylene amine oxime in systemic lupus erythematosus. Respiration 2002; 69:143-147.
12. Shih WJ, Gruenwald F, Biersack HJ, Berger R, Brandenburg S, Coupal J, Ryo UY. Tc-99m HMPAO diffuse pulmonary uptake demonstrated in cigarette smokers. Clin Nucl Med 1991; 16:668-672.
13. Kao CH,Wang RC, Lin HT, Yu SL, Wang SJ, Chiang CD. Alveolar integrity in pulmonary emphysema using technetium-99m-DTPA and technetium- 99m-HMPAO radioaerosol inhalation lung scintigraphy. J Nucl Med 1995; 36:68-72.
14. Shih WJ, Rehm SR, Grunwald F, Coupal JJ, Biersack HJ, Berger R, et al. Lung uptake of Tc-99m HMPAO in cigarette smokers expressed by lung/liver activity ratio. Clin Nucl Med 1993; 18:227-230.
15. Gunaydin B, Karadenizli Y, Babacan A, Kaya K, Unlu M, Inanir S, et al. Pulmonary microvascular injury following general anaesthesia with volatile anaesthetics - halothane and isoflurane: a comparative clinical and experimental study. Respir Med 1997; 91:351-360.
16. ATS Statement - snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979; 119:831-838.
17. Costa DC, Ell PJ, Cullum ID, Jarritt PH. The in vivo distribution of 99Tcm-HM-PAO in normal man. Nucl Med Commun 1986; 7:647-658.
18. American Diabetes Association. Standards of medical care in diabetes- 2010. Diabetes Care 2010; 33 (suppl 1):S11-S61.
19. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
20. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 1979; 120:973-983.
21. Innocenti F, Fabbri A, Anichini R, Tuci S, Pettinà G, Vannucci F, et al. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1994; 25:161-168.
22. Schnack C, Festa A, Schwarzmaier-D'Assié A, Haber P, Schernthaner G. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron 1996; 74:395-400.
23. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, et al. Diabetes mellitus, plasma glucose and lung function ina cross-sectional population study. Eur Respir J 1989; 2:14-19.
24. Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000; 50:153-159.
25. Behr J, Degenkolb B, Maier K, Braun B, Beinert T, Krombach F, et al. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur Respir J 1995; 8:1286-1292.
26. Suga K, Uchisako H, Nishigauchi K, Shimizu K, Kume N, Yamada N, et al. Technetium-99m-HMPAO as a marker of chemical and irradiation lung injury: experimental and clinical investigations. J Nucl Med 1994; 35:1520-1527.
27. Pazhanivel M, Jayanthi V. Diabetes mellitus and cirrhosis liver. Minerva Gastroenterol Dietol 2010; 56:7-11.
28. Huo TI,Wu JC, Lee PC, Tsay SH, Chang FY, Lee SD. Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J Clin Gastroenterol 2000; 30:250-254.
29. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405-412.
30. Ljubić S, Metelko Z, Car N, Roglić G, Drazić Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998; 114:1033-1035.
31. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31:741-746.
32. Engström G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 2002; 19:167-170.
33. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253:574-581.